• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗高血压药物对肾血管性高血压患者肾病范围蛋白尿的不同影响。

Different effects between antihypertensive drugs on nephrotic-range proteinuria in renovascular hypertension.

作者信息

Ishimitsu T, Yagi H, Ohkubo M, Nakamura Y, Yagi S

机构信息

Department of Medicine, Dokkyo University School of Medicine, Tochigi, Japan.

出版信息

Am J Nephrol. 1994;14(1):60-3. doi: 10.1159/000168687.

DOI:10.1159/000168687
PMID:7912475
Abstract

A 61-year-old man developed renovascular hypertension characterized by nephrotic-range proteinuria. When he was treated with a calcium channel blocker, glomerular filtration fraction was 0.26 and massive proteinuria ranging from 10 to 15 g/day persisted. An angiotensin-converting enzyme inhibitor markedly reduced the proteinuria to 1-2 g/day with a filtration fraction of 0.20. After the antihypertensive drug was switched to a beta-blocker, the filtration fraction was 0.23 and urinary protein excretion was 3-4 g/day. Blood pressure control was comparable by each drug. These findings suggest a role of intraglomerular hydraulic mechanism in the etiology of massive proteinuria in renovascular hypertension.

摘要

一名61岁男性患肾血管性高血压,其特征为肾病范围蛋白尿。当用钙通道阻滞剂治疗时,肾小球滤过分数为0.26,且持续存在每天10至15克的大量蛋白尿。一种血管紧张素转换酶抑制剂使蛋白尿显著减少至每天1 - 2克,滤过分数为0.20。在将抗高血压药物换为β受体阻滞剂后,滤过分数为0.23,尿蛋白排泄为每天3 - 4克。每种药物对血压的控制效果相当。这些发现提示肾小球内液压机制在肾血管性高血压大量蛋白尿的病因学中起作用。

相似文献

1
Different effects between antihypertensive drugs on nephrotic-range proteinuria in renovascular hypertension.抗高血压药物对肾血管性高血压患者肾病范围蛋白尿的不同影响。
Am J Nephrol. 1994;14(1):60-3. doi: 10.1159/000168687.
2
Equivalent reduction of proteinuria in hypertensives by either nifedipine GITS or enalapril: disparate effects on neurohormones and ambulatory blood pressure and the influence of salt.硝苯地平控释片或依那普利对高血压患者蛋白尿的等效降低作用:对神经激素和动态血压的不同影响以及盐的影响
Cardiology. 1997;88 Suppl 3:38-42. doi: 10.1159/000177505.
3
Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.原发性高血压患者降压治疗期间微量白蛋白尿发生的相关因素
Hypertension. 2002 Mar 1;39(3):794-8. doi: 10.1161/hy0302.105209.
4
Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.调整抗高血压治疗时间以降低慢性肾脏病患者的夜间血压:一项为期8周的非对照试验。
Am J Kidney Dis. 2007 Dec;50(6):908-17. doi: 10.1053/j.ajkd.2007.07.020.
5
Nephrotic-range proteinuria in a patient with high renin hypertension: effect of treatment with an ACE-inhibitor.
Am J Nephrol. 1992;12(5):387-9. doi: 10.1159/000168479.
6
Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.药物(比索洛尔与依那普利)顺序和类型对慢性心力衰竭患者结局和不良事件的影响:CIBIS-III 试验事后分析。
Eur J Heart Fail. 2011 Jul;13(7):765-72. doi: 10.1093/eurjhf/hfr051. Epub 2011 May 6.
7
Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.小剂量氯沙坦和依那普利对原发性肾小球肾炎患者的肾脏保护作用。短期观察。
Am J Nephrol. 2002 Jul-Aug;22(4):356-62. doi: 10.1159/000065227.
8
Disappearance of renin-induced proteinuria by an ACE-inhibitor: a case report.血管紧张素转换酶抑制剂使肾素诱导的蛋白尿消失:一例报告
Clin Nephrol. 1990 Aug;34(2):70-1.
9
Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.血管紧张素转换酶抑制可改善低钠血症性高血压综合征中肾小球大小选择性的缺陷。
Am J Kidney Dis. 1989 Sep;14(3):170-7. doi: 10.1016/s0272-6386(89)80067-8.
10
Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.口服蛋白质负荷后卡托普利、吲哚美辛和硝苯地平对肾病患者的肾脏影响。
Nephrol Dial Transplant. 1996 Apr;11(4):628-34. doi: 10.1093/oxfordjournals.ndt.a027351.